Simposios de la Industria

25 de febrero: 1:15 pm – 2:15 pm, hora de Buenos Aires (GMT -3)

Please complete the pre-test HERE before accessing the session.

After the session, please complete the evaluation HERE to obtain your CE credit.

 Speakers: Jill H. Simmons, MD, Karl L. Insogna, MD, FACP

Brief:

  • Overview: Phosphate Homeostasis
    • Renal Phosphate Handling
    • Role of Phosphatonins
  • Incidence and Prevalence of XLH and TIO
  • Pathogenesis and Clinical Manifestations of XLH and TIO
    • Differential Diagnoses and Diagnostic Criteria
    • Algorithms for the Evaluation of Children with Rickets Presenting with Hypophosphatemia
  • Safety and Efficacy of Treatments for Children and Adults with XLH and TIO
    • Burosumab
    • Phosphate and Calcitriol
    • Adjuvant Therapies
  • Treatment Challenges
    • Genetic Classification: PHEXMutational Analysis
    • Assessing Treatment Efficacy
    • Patient Follow-Up in Children and Adults with XLH and TIO

Learning Objectives

  • Describe the pathophysiological mechanisms of XLH and TIO ​
  • Evaluate the mechanisms, efficacy, and safety of agents approved for the treatment of XLH and TIO​
  • Develop personalized strategies for the long-term management of children and adults with XLH and TIO with ongoing disease monitoring and, when indicated, interdisciplinary clinical care

 (*) Supported by an educational grant from ULTRAGENYX

26 de febrero: 1:15 pm – 2:15 pm, hora de Buenos Aires (GMT -3)

Chair: Lynette Nieman

Speakers: Lynette Nieman, John Newell-Price, Elena Valassi

Brief:

  • Introduction – Lynette Nieman (Chair) (4´)
  • Managing Cushing’s syndrome in the COVID era – John Newell- Price (12´)
  • New evidence on metyrapone efficacy & safety: 12 weeks data from PROMPT – Lynette Nieman (12’)
  • What matters to patients with Cushing’s syndrome – Elena Valassi (12’)
  • Q & A (20´)

27 de febrero: 1:15 pm – 2:15 pm, hora de Buenos Aires (GMT -3)

Speakers: Bradley S. Miller, MD, PhD, Beverly Biller, MD

Brief:

  • Welcome, Introductions, Sponsor Acknowledgement, Disclosures (Bradley Miller) (1´)
  • Childhood-onset GHD transitioning to adult care: Diagnosis, Assessment, and Management Considerations (Bradley Miller, MD) (25´)
  • Adult GHD: Diagnostic Options, Clinical Challenges, and Treatment Options of GHD with Various Causes (Beverly Biller, MD)
  • Looking Ahead: Emerging Treatments for Prolonging GH Action including Long-term Management (Beverly Biller, MD) (25´)
  • Audience Q&A session (9´)

(*) Supported through an educational grant from NOVO NORDISK with CME credits from EXCEL – To obtain CME credits, please click here and complete the evaluation. (link available from February 27th)